Nadal JC - Search Results

1

Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.

Peters GJ, Van Dijk J, Nadal JC, Van Groeningen CJ, Lankelma J, Pinedo HM. Peters GJ, et al. Among authors: nadal jc. In Vivo. 1987 Mar-Apr;1(2):113-7. In Vivo. 1987. PMID: 2979771

2

Retention of in vivo antipyrimidine effects of Brequinar sodium (DUP-785; NSC 368390) in murine liver, bone marrow and colon cancer.

Peters GJ, Nadal JC, Laurensse EJ, de Kant E, Pinedo HM. Peters GJ, et al. Among authors: nadal jc. Biochem Pharmacol. 1990 Jan 1;39(1):135-44. doi: 10.1016/0006-2952(90)90657-7. Biochem Pharmacol. 1990. PMID: 2153375

3

Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma.

Nadal JC, van Groeningen CJ, Pinedo HM, Peters GJ. Nadal JC, et al. Invest New Drugs. 1989 Jul;7(2-3):163-72. doi: 10.1007/BF00170853. Invest New Drugs. 1989. PMID: 2793368

4

In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.

Nadal JC, Van Groeningen CJ, Pinedo HM, Peters GJ. Nadal JC, et al. Biomed Pharmacother. 1988;42(6):387-93. Biomed Pharmacother. 1988. PMID: 3064823 Review.

5

In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.

Peters GJ, van Dijk J, Laurensse E, van Groeningen CJ, Lankelma J, Leyva A, Nadal JC, Pinedo HM. Peters GJ, et al. Among authors: nadal jc. Br J Cancer. 1988 Mar;57(3):259-65. doi: 10.1038/bjc.1988.56. Br J Cancer. 1988. PMID: 3355763 Free PMC article.

6

Clinical and pharmacologic study of orally administered uridine.

van Groeningen CJ, Peters GJ, Nadal JC, Laurensse E, Pinedo HM. van Groeningen CJ, et al. Among authors: nadal jc. J Natl Cancer Inst. 1991 Mar 20;83(6):437-41. doi: 10.1093/jnci/83.6.437. J Natl Cancer Inst. 1991. PMID: 1999851

7

In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.

Peters GJ, Schwartsmann G, Nadal JC, Laurensse EJ, van Groeningen CJ, van der Vijgh WJ, Pinedo HM. Peters GJ, et al. Among authors: nadal jc. Cancer Res. 1990 Aug 1;50(15):4644-9. Cancer Res. 1990. PMID: 2164443

8

The relationship between dihydroorotic acid dehydrogenase and in vitro and in vivo cytostatic effects of brequinar sodium (DUP-785; NSC 368390).

Peters GJ, Laurensse E, de Kant E, Nadal JC, Pinedo HM. Peters GJ, et al. Among authors: nadal jc. Adv Exp Med Biol. 1989;253B:375-82. doi: 10.1007/978-1-4684-5676-9_55. Adv Exp Med Biol. 1989. PMID: 2558540 No abstract available.

9

Less efficacy with alternating regimen as adjuvant chemotherapy in stage II node-positive breast cancer: results at 8 years (Pronacam 85).

Chacon R, Romero Acuña L, Blajman C, Galvez C, Bruno M, Romero A, Chiessa G, Bader M, Schwan R, Albera C, Santarelli MT, Sousa Martínez F, Nadal J, Viniegra M. Chacon R, et al. Br J Cancer. 1997;76(4):545-50. doi: 10.1038/bjc.1997.423. Br J Cancer. 1997. PMID: 9275035 Free PMC article. Clinical Trial.

10

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.

O'Shaughnessy J, Sousa S, Cruz J, Fallowfield L, Auvinen P, Pulido C, Cvetanovic A, Wilks S, Ribeiro L, Burotto M, Klingbiel D, Messeri D, Alexandrou A, Trask P, Fredriksson J, Machackova Z, Stamatovic L; PHranceSCa study group. O'Shaughnessy J, et al. Eur J Cancer. 2021 Jul;152:223-232. doi: 10.1016/j.ejca.2021.03.047. Epub 2021 Jun 16. Eur J Cancer. 2021. PMID: 34147014 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters